Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Maharashtra Governor Vidyasagar Rao Felicitates Humanity Serviceman at the First Dr L H Hiranandani Award Event in Mumbai


News provided by

Dr L H Hiranandani Hospital

21 Jan, 2016, 15:00 IST

Share this article

Share toX

Share this article

Share toX

MUMBAI, January 21, 2016 /PRNewswire/ --

- Maharashtra Governor Vidyasagar Rao Delivers the First Dr L H Hiranandani Oration and Commemorates Contribution of the Ones who Have Used the Power of Health and Humanity to Serve the Society 

- Padma Bhushan Dr Suresh Advani, a Medical Oncologist, Conferred With the First Dr L H Hiranandani Award for his Immense Contribution in the Field of Cancer  

- Present at the Event was Honorable Former President of India, Pratibha Patil 

- Event Marks the Launch of the First Dr L H Hiranandani Award - an Initiative to Commemorate Individuals for Their Efforts Reflecting Humanity 

Humanity has been a virtue that has transformed societies and surroundings across the globe. There are nominated individuals who contribute and then there are volunteers, the unsung heroes who devote themselves for the betterment of the people around them. With a noble intent to honor the contributions and sacrifices of these 'individuals,' an endeavour to recognize their contribution has begun. The Dr L H Hiranandani Award launched in Mumbai amidst the presence of Honorable Governor of Maharashtra, Vidyasagar Rao and Honorable Former President of India, Pratibha Patil was a demonstration of that.

The first recipient of this recognition is Padma Bhushan Dr Suresh Advani - a medical oncologist par excellence and a pioneer of stem cell transplantation in Mumbai. The award was conferred by Governor Vidyasagar Rao in the presence of doctors, healthcare professionals and select invitees from the healthcare industry. The event was spearheaded by Niranjan Hiranandani, Co-founder and MD of Hiranandani Group and Dr Sujit Chatterjee, CEO of Dr L H Hiranandani Hospital.

Expressing his gratitude, Governor Vidyasagar Rao said, "I feel honored and privileged to deliver the first 'Dr L H Hiranandani' oration here in Mumbai. Dr Hiranandani dedicated his entire life to make specialized healthcare affordable to the common man. I am very happy that the Dr L H Hiranandani Hospital Trust has instituted an award in his name. Dr Advani has rendered outstanding service to the medical profession and to the society at large for more than four decades. I extend my heartiest congratulations to Dr Advani on being conferred the first Dr L H Hiranandani Award."  

Honorable Former President of India Pratibha Patil also addressed the gathering and said, "Dr . L H Hiranandani Hospital has been in the forefront of healthcare and a lot of initiatives. In addition, the hospital also leads in creating and spreading health awareness in the country. I heartily congratulate Dr Suresh Advani for receiving this prestigious award. I am known to Dr Advani's contribution and he is an excellent doctor who has surpassed limitations and earned a name in the world for his excellent skill."

Commenting on the event, Niranjan Hiranandani said, "Dr L H Hiranandani was a man respected and loved for his contributions in the field of healthcare, education, social work and human rights. His compassion for poor was evident with his relentless efforts in addressing their basic needs. The Dr L H Hiranandani Oration is a token of gratitude and recognition for contributions made by doctors on grounds of humanity and compassion." 

Dr Suresh Advani is a renowned oncologist in India and has over 650 publications to his credits. He has long been involved with medical oncology/hematology with strong interaction with clinical branches and basic scientists.

On winning the award, Dr Suresh Advani said,  "It always feels very humble to receive such a great honor in the name of a great person like Dr. L H Hiranandani. I had the privilege  of working with him. It is only his love and respect that he showed to everyone  around him that really impressed me. And it is with this humbleness I accept this honour and I will try to work in his shoes. He would see all his patients with great respect be it small patients, poor, rich. I hope I can follow his path and reach that follow his steps in the service of humanity."

Elaborating on the initiative, CEO of Dr L H Hiranandani Hospital, Dr Sujit Chatterjee said, "Many medical experts in their individual capacities have contributed significantly towards building a noble cause of securing health and offering innovation to encourage basic healthcare requirements. We are proud to present this award to Dr Suresh Advani who epitomizes the intent and purpose of this recognition."

The selection committee included members namely, Smt. Pratibha Patil, Chairman of the Award Committee, Shri Niranjan Hiranandani, Padma Shri Dr Rustom Soonawala, Dr Nischal Israni and Padma Vibhushan Dr B K Goyal.

About Dr L H Hiranandani Hospital 

Located at Powai in Mumbai, Dr L H Hiranandani Hospital is a 240 bed multi-specialty hospital. It is the first NABH accredited multi-specialty hospital in Mumbai and among the first few in India.

Website: http://www.hiranandanihospital.org/

Media Contact:
Parichita Bhattacharjee
[email protected]
+91-9702060253
Adfactors PR

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.